Holistic Approaches to Cardiometabolic Disease: Common Disease Pathology, Comorbidities & Combination Therapies

Time: 8:30 am
day: Day One


  • Obesity, cardiovascular disease, and diabetes: addressing the underlying common disease pathology and outcomes – what can we demonstrate in clinical trials?
  • GLP-1 receptor agonists: what are the next steps in treating cardiometabolic disease?
  • Human-centric approaches to drug development: how do we approach the holistic patient view in cardiometabolic disease from a pre-clinical perspectives in the future?